Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR.
about
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activityRapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaksCholera Toxin Subunit B as Adjuvant--An Accelerator in Protective Immunity and a Break in AutoimmunityEffect of vaccine administration modality on immunogenicity and efficacy.The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis BPlant-based anti-HIV-1 strategies: vaccine molecules and antiviral approaches.Recombinant expression, purification, and biophysical characterization of the transmembrane and membrane proximal domains of HIV-1 gp41.Expression, purification and crystallization of CTB-MPR, a candidate mucosal vaccine component against HIV-1.Plant-based vaccines against viruses.N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential.Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.Cholera toxin B: one subunit with many pharmaceutical applications.Immunological Characterization of Plant-Based HIV-1 Gag/Dgp41 Virus-Like Particles.Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamianaPlant-made immunogens and effective delivery strategies.In planta production of plant-derived and non-plant-derived adjuvants.Two decades of plant-based candidate vaccines: a review of the chimeric protein approaches.Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).The use of plants for the production of therapeutic human peptides.N-Glycosylation of Cholera Toxin B Subunit: Serendipity for Novel Plant-Made Vaccines?A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles.Characterization of two new monoclonal antibodies against human papillomavirus type 16 L1 protein.Meeting report VLPNPV: Session 5: Plant based technology.N-glycosylation and N-glycan moieties of CTB expressed in rice seeds.Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression.Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.Companion Protease Inhibitors for the In Situ Protection of Recombinant Proteins in Plants.
P2860
Q21076115-91AE928C-F8BC-46CF-9281-15B4628B2900Q21090119-A7F458A3-C87B-43D6-A031-B590A566A469Q26782576-502577FF-FB46-4C75-AFCA-0C23A868E7C6Q27692376-2732FCC6-EA94-4C09-978D-DFFE33D57553Q28073401-C797F583-5EA1-4BCB-A421-1033FC729747Q30392083-1D96EE1A-EE6D-4080-9EE0-06097F699D38Q30601090-FCE28E16-FAB3-4BB0-819A-10DDC3245DE2Q34242643-50D9314F-A788-482A-A75A-A1656997F869Q34687464-A4F22EC9-DC46-4371-B75C-41BA6AB25DB7Q35003962-E4CAAE65-73CD-43D0-88FA-23FDBBD8CAECQ35153426-E58EEBC7-08D9-488B-BB74-98D9D69AA875Q35174495-353D8E13-3A91-497E-9626-62D7AD61EB7FQ35232735-2835E7D2-7887-44D5-8B08-1920FE045B2DQ35960908-1B9DB040-75FD-4A67-9256-CA6222ED6898Q36944911-3E0A2163-4D04-44EB-B028-CBCC3B5D3963Q37776713-9125E534-9AEA-4A10-BBC1-5209B566553BQ37776716-26BDB2FB-AD75-432F-B5E2-D3F2E0F24FDDQ37867011-646266B9-F44B-48E6-A6AA-B94EDA74B815Q37967232-6A3BDDA3-43C0-4458-B8B2-2370DA881C7CQ37973256-6A0ED605-BB08-4145-8C7B-2EB55390FF7DQ40143890-1F148C83-5BBC-4002-9C9C-360FA30F5DDCQ40220988-E16F7C06-762A-4E71-895D-326D13DD18B9Q42048699-7BBD7E6B-534A-4523-94EC-5606A5C3DEEAQ42346870-61EE4D83-F7F5-4082-8513-15BE62A78273Q44961613-2BAE1E0F-DB47-486C-B473-20F3C608E26FQ49470037-76F16BE8-65B6-4CBB-B6BC-DEFFF4C9765AQ51059732-5ECAFF7C-7E0B-447D-8175-FA1AE918902CQ51626860-314A662E-75AF-4A51-B87E-A6227EE508BD
P2860
Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Biochemical and immunological ...... ype 1 mucosal vaccine CTB-MPR.
@ast
Biochemical and immunological ...... ype 1 mucosal vaccine CTB-MPR.
@en
type
label
Biochemical and immunological ...... ype 1 mucosal vaccine CTB-MPR.
@ast
Biochemical and immunological ...... ype 1 mucosal vaccine CTB-MPR.
@en
prefLabel
Biochemical and immunological ...... ype 1 mucosal vaccine CTB-MPR.
@ast
Biochemical and immunological ...... ype 1 mucosal vaccine CTB-MPR.
@en
P2093
P2860
P1476
Biochemical and immunological ...... type 1 mucosal vaccine CTB-MPR
@en
P2093
Hiroyuki Kajiura
Irene Cherni
Jeffrey D Doran
Kazuhito Fujiyama
Tsafrir S Mor
P2860
P304
P356
10.1111/J.1467-7652.2008.00381.X
P577
2008-11-17T00:00:00Z